MedTrace Logo

A Study of Renal Denervation in Patients With Treatment Resistant Hypertension

NCT01895140 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2014-10-13

No results posted yet for this study

Summary

The purpose of this study is to evaluate the clinical and economic impact of implementation of renal denervation with the Symplicity™ Catheter System for treatment-resistant hypertension in Ontario, Canada.

Conditions

  • Treatment-Resistant Hypertension

Interventions

DEVICE

Renal denervation device

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY

  • Mars Excellence in Clinical Innovation and Technology Evaluation

    collaborator OTHER

  • Dr. Harindra Wijeysundera

    lead OTHER

Principal Investigators

  • Harindra C. Wijeysundera, MD · Sunnybrook Research Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2014-10-31
Completion
2014-10-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01895140 on ClinicalTrials.gov